Beyfortus (Nirsevimab) RSV Antibody

Jul 11
2 min read

Second-Gen Passive Immunization Significantly Protects Infants from RSV

Beyfortus a recombinant human immunoglobulin G1 kappa long-acting mAbs that binds to the prefusion conformation of the RSV F protein
RSV
Respiratory Syncytial Virus (RSV)
+ 1
Jun 20
2 min read

U.S. CDC to Review Various Vaccines Next Week

ACIP to discuss dengue RSV and other vaccines
Respiratory Syncytial Virus (RSV)
May 2
4 min read

Passive Immunization Reduced RSV Related Infant Hospitalizations by 82%

Beyfortus reduces RSV related infant hospitalizations
RSV
Respiratory Syncytial Virus (RSV)
Apr 15
4 min read

Why Was the Maternal RSV Vaccine Study Stopped

RSVPreF3-Mat RSV prefusion F protein-based maternal vaccine development discontinued
RSV
Respiratory Syncytial Virus (RSV)
Mar 14
4 min read

Genomic Surveillance Lands at Chicago and Miami Airports

US CDC nasal sampling program provides information about a virus variant transmissibility
travel vaccine
Respiratory Syncytial Virus